Generic Name and Formulations:
Guanfacine (as HCl) 1mg, 2mg; tabs.
Promius Pharma, LLC
Indications for TENEX:
Initially 1mg/day at bedtime. May increase to 2mg/day at bedtime; usual max 3mg/day.
Severe coronary insufficiency. Recent MI. Cerebrovascular disease. Chronic renal or hepatic failure. Avoid abrupt cessation. Elderly. Labor & delivery: not recommended for treating hypertension due to pregnancy toxemia. Pregnancy (Cat.B). Nursing mothers.
Additive sedation with alcohol, other CNS depressants. Caution with microsomal enzyme inducing drugs (eg, barbiturates, phenytoin) in renal impairment.
Central alpha-2 agonist.
Dry mouth, somnolence, dizziness, headache, impotence, asthenia, constipation, fatigue.
Tabs 1mg—100, 500; 2mg—100
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Triiodothyronine in the Treatment of Bipolar Depression
- Antidepressants Increase Seizure Risk in Youth and Severely Depressed
- Intranasal Oxytocin Reduces Negative Effects, Improves Cognitive Function in Schizophrenia
- E-Cigarettes Associated With More Harms Than Benefits at Population Level
- Examining Rates of Long-Term Opioid Use in Youth With Psychiatric Disorders
- Suicide-Screening Toolkit Can Help Identify Youths at High Risk for Suicide
- Researchers Identify Novel Potential Biomarkers for Autism
- Agoraphobia: An Evolving Understanding of Definitions and Treatment
- Parental Pressure to Diet Linked With Long-term Harm in Adolescents
- Does Access to Medical Cannabis Reduce Risk for Opioid Abuse?
- Supported Employment vs Transitional Work in Veterans With PTSD
- Comparing Pharmacologic Treatments for Prevention of Rehospitalization in BP
- Preliminary Evidence Suggests Suicidal Thinking Is Self-Reinforcing
- Lower Fluoxetine Efficacy in Elderly Patients With Major Depressive Disorder
- Personal Health Information Found in Recycling